Corix Biosciences, Inc. (OTCQB: CXBS) GW Pharmaceuticals
(NASDAQ: GWPH) Should Acquire
this Company.
Patenting Cannabis and Hemp Strands for FDA Approval Expecting
$58 million in revenue
Miami, FL -- (InvestorsHub NewsWire August 16, 2017)
EmergingGrowth.com, a leading independent small cap media portal
with an extensive history of providing unparalleled content for the
Emerging Growth markets and companies, reports on Corix
Biosciences, Inc. (OTCQB: CXBS).
CXBS may not be at these levels much
longer.
See the Full Press Release and other
stories on Corix Biosciences, Inc. (OTCQB: CXBS) at
EmergingGrowth.com
http://emerginggrowth.com/?s=cxbs
Corix Biosciences, Inc. (OTCQB: CXBS), as the first major
player for applications for cancer, the opioid epidemic, and other
illnesses and diseases, will patent cannabis and hemp strains for
FDA approval that have direct connections to specific ailments.
CXBS just announced a major sales agreement with Positively
Green Organics, LLC. (PGO) to sell up to 22,000 pounds of hemp from
150 acres of PGOs harvest monthly.
Under the agreement, PGO will deliver their industrial hemp
flower or "bud," to one of Corix's facilities, where Corix will
package it for storage and then sell the product on the open
pharmaceutical market where it can bring approximately $575 per
pound. The sales of the hemp will yield Corix 34% of the gross
proceeds.
Michael Ogburn, CEO of Corix Bioscience, Inc., stated, "We are
very excited about this agreement and expect to generate over $50
million in revenue over the next 12 months as we are
currently fielding several calls per day from purchasers of hemp,
CBD oil, and raw flower."
CXBS also recently announced that on August 1st, they moved
their tissue cell culture and research divisions into a new 10,122
square foot laboratory in Carson City Nevada, enabling them to
produce over 3 million plantlets in the immediate future and 6
million in year two.
CXBS expects to sell 2.2 million of plantlets which will add $8
million in revenue.
On June 5, 2017, Corix Bioscience, Inc. (OTCQB: CXBS) announced it has
signed a contract with Segra International, Inc. to build a
state-of-the-art tissue culture facility in Nevada. The new
facility will allow the company to begin making adjustments
to cannabis seed cells and ultimately, its DNA. The goal is to
create strains with greater production, stability, and higher
yield. These newly developed strains is what will be patented.
CXBS may not be at these levels much
longer.
See the Full Press Release and other
stories on Corix Biosciences, Inc. (OTCQB: CXBS) at
EmergingGrowth.com
http://emerginggrowth.com/?s=cxbs
Other Emerging Growth News
BTCS, Inc.
Shares of BTCS, Inc., (OTCQB: BTCS) have traded up 500% over
six of the last trading sessions beginning three days prior to the
company announcing its letter to shareholders. The letter discussed
(subject to the completion of additional financing) a plan to
create a portfolio of digital assets. However, as one digital
currency, Bitcoin, saw a 10% drop yesterday from a high of 4,400 to
3,900, so did shares of BTCS, Inc., giving back almost 50% of is
previous days high.
Have a look at Corix Biosciences, Inc. (OTCQB: CXBS)
On The Move Systems Corp.
On The Move Systems Corp., (OTC Pink: OMVS) is another one who has
seen a dramatic rise to the tune of 1,400% over the past ten weeks.
The company gave back 42% two trading sessions ago however,
recovered slightly yesterday. Candlesticks are pointing neutral,
however the Bollinger Bands appear to be tightening.
First Bitcoin Capital Corp.
First Bitcoin Capital Corp.s (OTC: BITCF) shares began trading out
of the blue just about six sessions ago, two days before the
company announced that SinglePoint, Inc. purchased $Weed as money
from its joint venture partner. Since, shares have spiked 800% to
$3.30 before giving back almost 50% yesterday.
The company addressed its sudden spike in valuation and
cautioned investors by stating that the demand for its common
shares has reached unrealistic heights, and that the exuberance for
not only their own common shares, but for that of all in this
space, is far outpacing performance and realistic expectations.
Have a look at Corix Biosciences, Inc. (OTCQB: CXBS). This company seems
to have a lot more going for it than the market is giving it credit
for.
About EmergingGrowth.com
EmergingGrowth.com is a leading independent small cap media
portal with an extensive history of providing unparalleled content
for the Emerging Growth markets and companies. Through its
evolution, EmergingGrowth.com found a niche in identifying
companies that can be overlooked by the markets due to, among other
reasons, trading price or market capitalization. We look for strong
management, innovation, strategy, execution, and the overall
potential for long- term growth. Aside from being a trusted
resource for the Emerging Growth info-seekers, we are well known
for discovering undervalued companies and bringing them to the
attention of the investment community. Through our parent Company,
we also have the ability to facilitate road shows to present your
products and services to the most influential investment banks in
the space.
All information contained herein as well as on the
EmergingGrowth.com website is obtained from sources believed to be
reliable but not guaranteed to be accurate or all-inclusive. All
material is for informational purposes only, is only the opinion of
EmergingGrowth.com and should not be construed as an offer or
solicitation to buy or sell securities. The information may include
certain forward-looking statements, which may be affected by
unforeseen circumstances and / or certain risks. This report
is not without bias. EmergingGrowth.com has motivation by means of
either self-marketing or EmergingGrowth.com has been compensated by
or for a company or companies discussed in this article. Full
details about which can be found in our full disclosure, which
can be found here, http://emerginggrowth.com/722448-2/ Please
consult an investment professional before investing in anything
viewed within. When EmergingGrowth.com is long shares it will sell
those shares. In addition, please make sure you read and understand
the Terms of Use, Privacy Policy and the Disclosure posted on the
EmergingGrowth.com website.
CONTACT:
Company: EmergingGrowth.com - http://www.EmergingGrowth.com
Contact Email: info@EmergingGrowth.com
